- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Milestone Pharmaceuticals (NASDAQ:MIST), Quotes and News Summary
Milestone Pharmaceuticals (NASDAQ: MIST)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-10 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.390 | -0.330 | 0.0600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Milestone Pharmaceuticals Questions & Answers
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Other companies in Milestone Pharmaceuticals’s space includes: WAVE Life Sciences (NASDAQ:WVE), Verona Pharma (NASDAQ:VRNA), CymaBay Therapeutics (NASDAQ:CBAY), Provention Bio (NASDAQ:PRVB) and Rani Therapeutics Hldgs (NASDAQ:RANI).
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by Piper Sandler on Friday, April 22, 2022. The analyst firm set a price target for 10.00 expecting MIST to rise to within 12 months (a possible 70.65% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $5.86 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Milestone Pharmaceuticals.
Milestone Pharmaceuticals’s Q2 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for Milestone Pharmaceuticals.
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.